Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:688050's PS Ratio is ranked worse than 71.48% of 803
companies
in the Medical Devices & Instruments industry
Industry Median: 2.87
vs SHSE:688050: 5.34
Eyebright Medical Technology (Beijing) Co (SHSE:688050) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Eyebright Medical Technology (Beijing) Co PS Ratio Related Terms
Eyebright Medical Technology (Beijing) Co PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eyebright Medical Technology (Beijing) Co PS Ratio Chart
Eyebright Medical Technology (Beijing) Co Annual Data
SHSE:688050 vs ISRG, BDX, MDLN: PS Ratio Comparison
For the Medical Instruments & Supplies subindustry, Eyebright Medical Technology (Beijing) Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eyebright Medical Technology (Beijing) Co PS Ratio vs Medical Devices & Instruments Industry
Eyebright Medical Technology (Beijing) Co PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Eyebright Medical Technology (Beijing) Co's Share Price of today is ¥42.22. Eyebright Medical Technology (Beijing) Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥7.90.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Eyebright Medical Technology (Beijing) Co (SHSE:688050) has a PS Ratio of 5.34 as of Jul. 30, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Eyebright Medical Technology (Beijing) Co and its competitors. This is 80% below median its historical median of 26.85. Over the past decade, Eyebright Medical Technology (Beijing) Co's PS Ratio has ranged from 4.59 to 98.02. According to the industry distribution chart, Eyebright Medical Technology (Beijing) Co ranks #574 out of 803 companies in the Medical Devices & Instruments industry, placing it in the top 71.5%.
Is Eyebright Medical Technology (Beijing) Co's PS Ratio too high?
Eyebright Medical Technology (Beijing) Co's current PS Ratio of 5.34 is 80% below median its 10-year median of 26.85. Over the past 10 years, this metric has ranged from a low of 4.59 to a high of 98.02. The Medical Devices & Instruments industry median PS Ratio is 2.87. Eyebright Medical Technology (Beijing) Co's value of 5.34 is 86.1% above this industry median. Based on the distribution chart, Eyebright Medical Technology (Beijing) Co ranks #574 out of 803 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Eyebright Medical Technology (Beijing) Co has a GF Score™ of 80/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Eyebright Medical Technology (Beijing) Co's PS Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Eyebright Medical Technology (Beijing) Co ranks #574 out of 803 companies for PS Ratio. This places Eyebright Medical Technology (Beijing) Co in the lower half of its industry. The industry median PS Ratio is 2.87. Eyebright Medical Technology (Beijing) Co's value of 5.34 is 86.1% above this benchmark. Historically, Eyebright Medical Technology (Beijing) Co's own PS Ratio has ranged from 4.59 to 98.02 over the past decade. While the company's 10-year median is 26.85 vs. the industry median of 2.87, Eyebright Medical Technology (Beijing) Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.87, based on 803 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eyebright Medical Technology (Beijing) Co's current PS Ratio of 5.34 is 86.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Eyebright Medical Technology (Beijing) Co and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eyebright Medical Technology (Beijing) Co's current PS Ratio is 5.34, which is 80% below median its own 10-year median of 26.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eyebright Medical Technology (Beijing) Co stock overvalued right now?
Based on GuruFocus' analysis, Eyebright Medical Technology (Beijing) Co (SHSE:688050) is currently considered Possible Value Trap. The stock's GF Value™ is ¥112.82, compared to a current price of ¥42.22 — trading 62.6% below its estimated fair value. The current PS Ratio is 5.34, which is 80% below median its 10-year median of 26.85 and 86.1% above the Medical Devices & Instruments industry median of 2.87. Eyebright Medical Technology (Beijing) Co's overall GF Score™ is 80/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Eyebright Medical Technology (Beijing) Co (SHSE:688050), the current PS Ratio is 5.34 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eyebright Medical Technology (Beijing) Co (SHSE:688050) Overvalued in 2026?
Based on GuruFocus' analysis, Eyebright Medical Technology (Beijing) Co stock appears to be undervalued.
The current stock price of ¥42.22 is trading 62.6% below its estimated GF Value™ of ¥112.82.
GuruFocus considers Eyebright Medical Technology (Beijing) Co to be Possible Value Trap.
Key valuation signals for SHSE:688050:
PS Ratio: 5.34 (80% below median its 10-year median of 26.85)
GF Value™: ¥112.82 vs. price of ¥42.22 (62.6% below fair value)
Industry Position: 86.1% above the Medical Devices & Instruments median (#574 of 803)
No single metric tells the full story. See the SHSE:688050 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eyebright Medical Technology (Beijing) Co Business Description
Eyebright Medical Technology (Beijing) Co Ltd is engaged in research and development, production, sales and related services of ophthalmic medical devices. The company's product range includes Intraocular Lens; IOL Delivery System; Ophthalmic Instruments; Other Products; Literature; and Expert Interview.
80GF Score
Get the complete analysis for SHSE:688050
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688050 has been successfully added to your 
